CME/CE Information
Target Audience
This activity is intended for neurologists, primary care providers, nursing professionals,
physician assistants, rehabilitation specialists, mental health professionals, and
other healthcare providers involved in the treatment of MS.
|
|
|
Activity Purpose
The purpose of this activity is to address the practitioner and patient barriers
in the optimal management of MS-related symptoms, and to identify best practices
in employing treatments for complex patient cases.
|
|
|
Statement of Need
Disease progression, severity of disease course, and occurrence of specific symptoms
in multiple sclerosis (MS), an autoimmune disorder of the brain and spinal cord,
are unpredictable and vary from person to person. The symptoms of MS and its treatment
have significant consequences on all aspects of life, from physiologic to daily
function. Treatment of MS-related symptoms is a complex, individualized process
and the development of universally-agreed upon quality measures or guidelines has
proved extremely difficult. Therefore, clinicians treating patients with MS need
expert recommendations and guidance from MS specialists to differentiate symptomatic
care from disease management, and reduce the risk of worsening disease due to secondary
complications.
|
|
|
Learning Objectives
Upon completion of this activity, participants will
- Apply screening and assessment tools to determine risk in patients who are likely
to suffer from MS-related symptoms
- Analyze and implement evidence-based therapeutic interventions designed to prevent
disability and improve quality of life in patients with MS
- Evaluate the efficacy of nonpharmacologic and pharmacologic treatment approaches
for symptom management
- Formulate and monitor treatment strategies for MS symptoms based on patient characteristics
and preferences
|
|
|
Accreditation and Credit Designation
|
|
|
This activity has been planned and implemented in accordance with the Essential
Areas and policies of the Accreditation Council for Continuing Medical Education
through the joint sponsorship of the Consortium of Multiple Sclerosis Centers (CMSC),
Nurse Practitioner Alternatives (NPA), and the Academy for Continued Health Learning
(ACHL). CMSC is accredited by the ACCME to provide continuing medical education
for physicians.
The Consortium of Multiple Sclerosis Centers designates this live activity for a
maximum of 1.5 AMA PRA Category 1 Credits™. Physicians
should claim only the credit commensurate with the extent of their participation
in the activity.
This activity is co-provided by the CMSC, NPA, and ACHL.
Nurse Practitioner Alternatives (NPA) is accredited as a provider of continuing
nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity has been awarded 1.5 contact hours for nurses and
advanced practice nurses.
Accreditation does not imply endorsement by NPA, CMSC, ACHL, or ANCC of recommendations
or any commercial products displayed or discussed in conjunction with the educational
activity.
This program has been pre-approved by The Commission for Case Manager Certification
to provide continuing education credit to CCM® board certified case managers. The
course is approved for 1.5 CE contact hours. |
|
|
Method of Participation
This activity will consist of lectures that include case study discussions with
slides, syllabi, and an interactive question and answer session. To receive credit,
participants are required to complete the enrollment/evaluation form and submit
on-site. A certificate will be emailed to participants within 6 weeks of receipt
of the form. There is no fee to participate in the activity or for the generation
of the certificate.
|
|
|
Disclosure Information
Current guidelines require that participants in CME/CE activities be made aware
of all affiliations or financial interests that may be perceived as affecting the
presentation of the faculty member. CMSC, NPA, and ACHL ensure that all faculty
and staff involved in the planning, development, and implementation of activities
disclose all potential conflicts of interest and resolve them before the CME/CE
activity occurs. Complete information will be provided to participants prior to
the start of the educational activity.
|
|
|
Funding Statement
This activity is supported by educational grants from Acorda Therapeutics, Inc.,
Allergan Inc., and Novartis Pharmaceuticals Corporation.
|
|
|
Preregistration and Registration
|
Please call (877) 444-8435, ext. 160 prior to your arrival if you have special needs
that we can address to make your participation more enjoyable. |
|
Initiate a Multiple Sclerosis Virtual Visiting
Professorship Program
|
|
Click below to initiate a virtual VPP:
|
|
|
|
Jointly sponsored by the Consortium of Multiple Sclerosis Centers (CMSC), Nurse
Practitioner Alternatives (NPA) and The Academy for Continued Healthcare Learning
(ACHL).
|
 |
|
|
|
This activity is supported by educational grants from Acorda Therapeutics, Inc.,
Allergan Inc., and Novartis Pharmaceuticals Corporation. |
|
|
 |
|
|
